HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Very early recurrence of anti-Phospholipase A2 receptor-positive membranous nephropathy after transplantation.

Abstract
Membranous nephropathy is a common cause of adult nephrotic syndrome, with recent evidence suggesting that 70% of idiopathic disease is associated with anti-Phospholipase A(2) receptor autoantibodies. We describe a 63-year-old man with membranous nephropathy who underwent a kidney transplant and developed recurrent membranous nephropathy with fine granular co-localization of Phospholipase A(2) receptor and IgG evident on transplant biopsy on day 6 and elevated circulating levels of serum anti-Phospholipase A(2) receptor autoantibody that declined over time in conjunction with improvement in the serum creatinine and urinary protein. This is a very early case of Phospholipase A(2) receptor-associated recurrent membranous nephropathy with circulating anti-Phospholipase A(2) receptor autoantibody, which supports the emerging evidence that idiopathic membranous nephropathy is an autoimmune disease.
AuthorsC D Blosser, R Ayalon, R Nair, C Thomas, L H Beck Jr
JournalAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (Am J Transplant) Vol. 12 Issue 6 Pg. 1637-42 (Jun 2012) ISSN: 1600-6143 [Electronic] United States
PMID22390840 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© Copyright 2011 The American Society of Transplantation and the American Society of Transplant Surgeons.
Chemical References
  • Autoantibodies
  • Receptors, Phospholipase A2
Topics
  • Autoantibodies (immunology)
  • Glomerulonephritis, Membranous (immunology, pathology, surgery)
  • Humans
  • Kidney Transplantation
  • Male
  • Middle Aged
  • Receptors, Phospholipase A2 (immunology)
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: